Tobacco Cessation Program among Cab Drivers in Mumbai, India: An Interventional Study
Gauravi Ashish Mishra1, Sharmila A Pimple1, Vasundhara Y Kulkarni1
1Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
A tobacco cessation program for Mumbai cab drivers significantly reduced tobacco use, with nearly half quitting and many reducing consumption. This intervention highlights effective strategies for workplace tobacco control.
Area of Science:
- Public Health
- Occupational Health
- Tobacco Control
Background:
- The global tobacco epidemic causes millions of deaths annually.
- Indian smoke-free legislation mandates smoke-free public places, including cabs.
- A majority of cab drivers in India remain addicted to tobacco despite legislation.
Purpose of the Study:
- To assess cab drivers' knowledge, attitudes, and practices regarding tobacco use before and after an intervention.
- To educate cab drivers on tobacco hazards and the importance of smoke-free cabs.
- To offer oral cancer screening and tobacco cessation support.
Main Methods:
- An interventional study conducted in Mumbai from 2015-2018.
- 400 cab drivers were enrolled and received health education, oral cancer screening, and cessation assistance over one year.
- Data collected on tobacco use, quit attempts, and need for assistance.
Main Results:
- 63.8% of cab drivers used tobacco, primarily smokeless forms.
- Nearly 94.1% intended to quit, and 69.8% desired cessation assistance.
- 49.4% quit tobacco, and 46.7% reduced consumption; 112 drivers had oral precancerous lesions, and one had oral cancer.
Conclusions:
- Workplace tobacco cessation programs can be successfully implemented and replicated.
- Adherence to smoke-free laws is crucial for reducing secondhand smoke exposure.
- Targeted interventions are effective in promoting tobacco cessation among high-risk occupational groups.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Dependence
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
